Barclays Lowers Zimmer Biomet (NYSE:ZBH) Price Target to $112.00
Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price target lowered by Barclays from $118.00 to $112.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “underweight” rating on the medical equipment provider’s stock. Barclays‘s target price points to a potential upside of 12.98% from the stock’s current […]
Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price target lowered by Barclays from $118.00 to $112.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “underweight” rating on the medical equipment provider’s stock. Barclays‘s target price points to a potential upside of 12.98% from the stock’s current […]
